FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, specifically to polypeptides that bind to interleukin-17А (IL-17A), and can be used in medicine.
EFFECT: resulting IL-17A-binding polypeptides containing the sequence 
can be effectively used as a diagnostic or therapeutic agent of a IL-17A-associated condition.
25 cl, 15 dwg, 21 tbl, 21 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL POLYPEPTIDES | 2015 |
|
RU2725442C2 |
| ANTI-PVRIG ANTIBODIES AND METHODS OF USING | 2016 |
|
RU2732042C2 |
| IL-12 HETERODIMERIC FC FUSION PROTEINS | 2019 |
|
RU2819097C2 |
| ANTIBODIES AGAINST CXCR2 AND THEIR USE | 2019 |
|
RU2807067C2 |
| ANTI-IL-17A ANTIBODY AND USE THEREOF | 2019 |
|
RU2816204C2 |
| ELEMENTS THAT BIND TO IL-1 BETA | 2013 |
|
RU2711118C2 |
| POLYPEPTIDES RECRUITING T-CELLS, CAPABLE OF BINDING CD123 AND ALPHA/BETA TCR | 2017 |
|
RU2775063C2 |
| IMMUNOCYTOKINES BASED ON IL-15 AND IL-15Rα OF THE SUSHI DOMAIN | 2012 |
|
RU2763298C2 |
| NEONATAL Fc RECEPTOR BINDING AFFIMERS | 2020 |
|
RU2817008C1 |
| ANTI-C10orf54 ANTIBODIES AND APPLICATIONS THEREOF | 2015 |
|
RU2819627C1 |
